<DOC>
	<DOCNO>NCT01600885</DOCNO>
	<brief_summary>The purpose study 1 . To establish feasibility fMRI study interaction guanfacine ketamine . 2 . To explore possibility guanfacine ameliorate negative effect ketamine task-related prefrontal activation . 3 . To assess strength interaction guanfacine ketamine .</brief_summary>
	<brief_title>The Effects Ketamine Guanfacine Working Memory Healthy Subjects</brief_title>
	<detailed_description>Potential subject interview phone , appropriate , scheduled screening session . Participants meet study criterion participate two study session separate least two week . The session identical except one day receive guanfacine , receive placebo .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Age 21 45 , inclusive Righthanded Have least 12th grade education level equivalent Able read write English primary language Willing refrain caffeine alcohol use one week prior MRI session . Abnormality physical examination A 12 lead ECG screen clinically significant abnormality determine physician reading ECG A positive prestudy urine drug screen , study physician ' discretion drug screen give scan Abnormality clinical chemistry hematology examination prestudy medical screening . History positive HIV Hepatitis B . Has receive either prescribe overthecounter ( OTC ) centrally active medicine herbal supplement within week prior MRI scan . History substance abuse disorder meeting DSMIV criterion exception nicotine Any history DSMIV Axis I psychiatric disorder , Any history major medical neurological disorder Any history indicating learn disability , mental retardation , attention deficit disorder . Firstdegree relative Axis I DSMIV disorder include substance abuse dependence . Any clinically significant abnormality screen electrocardiogram Any history head injury Any evidence psychosislike symptom , indicate elevated score Perceptual AberrationMagical Ideation ( Chapman , Chapman et al . 1978 ; Eckblad , Chapman et al . 1983 ) revise Social Anhedonia scale ( Eckblad , Chapman et al . unpublished ) A positive urine toxicology screen illicit substance use positive alcohol breathalyzer test conduct screen interview prior MRI session Known sensitivity ketamine . Body circumference 52 inch great . History claustrophobia Any clinically significant impairment color vision visual acuity correction available scanner . Presence cardiac pacemaker electronic device ferromagnetic metal foreign body vulnerable position assess standard preMRI screen questionnaire Pregnancy breastfeeding would exclude potential participant female subject receive urine pregnancy test screen MRI scan . Donation blood excess 500 mL within 56 day prior dose . History sensitivity heparin heparininduced thrombocytopenia . Blood pressure must higher 90/70 . Pulse must great 40 unless participant clear study physician</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Guanfacine</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Functional Magnetic Resonance Imaging</keyword>
	<keyword>Prefrontal Cortex Activity</keyword>
	<keyword>Receptors , N-Methyl-D-Aspartate</keyword>
	<keyword>Receptors , Adrenergic , alpha-2</keyword>
	<keyword>Memory , Short-Term</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>